Objectives: The aim of this study was to evaluate the 1-year safety and efficacy of a dual-layered stent (DLS) for carotid artery stenting (CAS) in a multicenter registry. Background: DLS have been proved to be safe and efficient during short-term follow-up. Recent data have raised the concern that the benefit of CAS performed with using a DLS may be hampered by a higher restenosis rate at 1 year. Methods: From January 2017 to June 2019, a physician-initiated, prospective, multispecialty registry enrolled 733 consecutive patients undergoing CAS using the CGuard embolic prevention system at 20 centers. The primary endpoint was the occurrence of death and stroke at 1 year. Secondary endpoints were 1-year rates of transient ischemic attack, acute myocardial infarction, internal carotid artery (ICA) restenosis, in-stent thrombosis, and external carotid artery occlusion. Results: At 1 year, follow-up was available in 726 patients (99.04%). Beyond 30 days postprocedure, 1 minor stroke (0.13%), four transient ischemic attacks (0.55%), 2 fatal acute myocardial infarctions (0.27%), and 6 noncardiac deaths (1.10%) occurred. On duplex ultrasound examination, ICA restenosis was found in 6 patients (0.82%): 2 total occlusions and 4 in-stent restenoses. No predictors of target ICA restenosis and/or occlusion could be detected, and dual-antiplatelet therapy duration (90 days vs 30 days) was not found to be related to major adverse cardiovascular event or restenosis occurrence. Conclusions: This real-world registry suggests that DLS use in clinical practice is safe and associated with minimal occurrence of adverse neurologic events up to 12-month follow-up.

Sirignano, P., Stabile, E., Mansour, W., Capoccia, L., Faccenna, F., Intrieri, F., et al. (2021). 1-year results from a prospective experience on CAS using the CGuard stent system: the IRONGUARD 2 study. JACC. CARDIOVASCULAR INTERVENTIONS, 14(17), 1917-1923 [10.1016/j.jcin.2021.05.045].

1-year results from a prospective experience on CAS using the CGuard stent system: the IRONGUARD 2 study

Ippoliti A.;
2021

Abstract

Objectives: The aim of this study was to evaluate the 1-year safety and efficacy of a dual-layered stent (DLS) for carotid artery stenting (CAS) in a multicenter registry. Background: DLS have been proved to be safe and efficient during short-term follow-up. Recent data have raised the concern that the benefit of CAS performed with using a DLS may be hampered by a higher restenosis rate at 1 year. Methods: From January 2017 to June 2019, a physician-initiated, prospective, multispecialty registry enrolled 733 consecutive patients undergoing CAS using the CGuard embolic prevention system at 20 centers. The primary endpoint was the occurrence of death and stroke at 1 year. Secondary endpoints were 1-year rates of transient ischemic attack, acute myocardial infarction, internal carotid artery (ICA) restenosis, in-stent thrombosis, and external carotid artery occlusion. Results: At 1 year, follow-up was available in 726 patients (99.04%). Beyond 30 days postprocedure, 1 minor stroke (0.13%), four transient ischemic attacks (0.55%), 2 fatal acute myocardial infarctions (0.27%), and 6 noncardiac deaths (1.10%) occurred. On duplex ultrasound examination, ICA restenosis was found in 6 patients (0.82%): 2 total occlusions and 4 in-stent restenoses. No predictors of target ICA restenosis and/or occlusion could be detected, and dual-antiplatelet therapy duration (90 days vs 30 days) was not found to be related to major adverse cardiovascular event or restenosis occurrence. Conclusions: This real-world registry suggests that DLS use in clinical practice is safe and associated with minimal occurrence of adverse neurologic events up to 12-month follow-up.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/22
English
carotid artery disease
carotid artery stenting
stroke
Carotid Artery, Internal
Humans
Prospective Studies
Stents
Treatment Outcome
Carotid Stenosis
Sirignano, P., Stabile, E., Mansour, W., Capoccia, L., Faccenna, F., Intrieri, F., et al. (2021). 1-year results from a prospective experience on CAS using the CGuard stent system: the IRONGUARD 2 study. JACC. CARDIOVASCULAR INTERVENTIONS, 14(17), 1917-1923 [10.1016/j.jcin.2021.05.045].
Sirignano, P; Stabile, E; Mansour, W; Capoccia, L; Faccenna, F; Intrieri, F; Ferri, M; Sacca, S; Sponza, M; Mortola, P; Ronchey, S; Praquin, B; Grillo, P; Chiappa, R; Losa, S; Setacci, F; Pirrelli, S; Taurino, M; Ruffino, Ma; Udini, M; Palombo, D; Ippoliti, A; Montelione, N; Setacci, C; de Donato, G; Ruggeri, M; Speziale, F
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/296895
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 0
social impact